I'm sitting here thinking about that PR this morning, and I
I'm sitting here thinking about that PR this morning, and I just keep getting more ticked off about it.
Yes, I know that Generex was working on the Swine Flu vaccine in the past and they went through a trial already. But Joe made it perfectly clear, they needed funding to get the Covid Vaccine moving.
If they need funding for that, how in the world are they going to get this Swine Flu Vaccine moving?
I don't know about anyone else, but anyone with any common sense looks at this and sees that they pushed and pushed the need for funding to get a vaccine going and then no news at all coming forward on any funding whatsoever and then Generex comes out with this PR saying they are going to work on ANOTHER vaccine when they haven't even said they were able to get funding on the first vaccine they are working on - COVID19. It's getting harder to believe Joe and Generex.
It's about time they show something real to their shareholders instead of just a PR with words about what they will be doing. They need to show what they HAVE for a change. How about showing some financial means to their shareholders.
Rant over.
3
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
IntelAgree Recognized for Innovation in CLM IntelAgree, a leading player in contract lifecycle management (CLM) powered by artificial intelligence, has recently been honored as an 'Advanced Solution' in a distinguished analysis by The Hackett Group. This recognition solidifies IntelAgree’s reputation as a top platform in the business sector. Importance of The Hackett...
Continue Reading
Emergency Health Professionals Unite with Teamsters Local 120 Recently, a remarkable development unfolded as a dedicated group of 15 paramedics, EMTs, and emergency health professionals came together to join Teamsters Local 120. This resolute decision signifies their commitment to securing better working conditions and fair compensation. The Journey Toward Unionization...
Continue Reading
MSI Unveils Future-Proof Cloud Solutions At CloudFest 2025, MSI, a leader in high-performance server solutions, introduced its innovative next-generation server platforms, including the ORv3 Servers, DC-MHS Servers, and NVIDIA MGX™ AI Servers. This significant event showcased MSI's commitment to enhancing cloud infrastructure with a focus on scalability, performance,...
Continue Reading
St. Cloud Capital's Growth Capital Investment St. Cloud Capital has proudly announced a significant investment in Integrated Diagnostic Services (IDS). This initiative focuses on expanding their capabilities in mobile radiology and laboratory services. The investment aims to support IDS in acquiring Core Analytics Lab & Radiology, a leading provider in California....
Continue Reading
LeMaitre Vascular Shows Robust Growth in Q3 2024 BURLINGTON, Mass. – LeMaitre Vascular, Inc. (NASDAQ: LMAT), a leading provider of vascular devices and services, has reported exceptional results for the third quarter of 2024. The company’s strong performance demonstrates its commitment to innovation in the medical device sector, especially in the area of vascular...
Continue Reading